drugset / Trial / NCT00148564

Energy Homeostasis Under Treatment With Atypical Antipsychotics

NCT00148564

Phase 4 Completed 40 enrolled Charite University, Berlin, Germany
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of different atypical antipsychotics on weight changes, energy homeostasis, metabolism, energy intake as well as activity. Patients with schizophrenia or schizoaffective disorders will be randomly assigned to be treated with ziprasidone or olanzapine for 24 weeks. Primary outcome parameter are the weight changes after 24 weeks.

Timeline

Start
2004-03
Primary completion
2007-03
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olanzapine Small molecule
Comparator Ziprasidone Small molecule

Indications